IDx

IDx is a leading artificial intelligence (AI) diagnostics company based in Coralville, Iowa. Founded in 2010, the company employs 13 people and generates revenue exceeding $10,000. IDx is dedicated to revolutionizing healthcare by enhancing its quality, accessibility, and affordability through the development of cutting-edge AI-powered diagnostic solutions. IDx specializes in creating clinically-aligned autonomous algorithms that detect diseases within medical images. Their flagship product, IDx-DR, is an FDA-cleared AI-based diagnostic system designed for use in primary care settings to detect diabetic retinopathy. The company is actively developing additional AI-based algorithms for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk. IDx's mission centers around bringing high-quality, affordable disease detection to patients through the use of AI. Their technology aims to empower primary care providers by enabling them to conduct accurate diagnostic assessments, ultimately improving patient care and accessibility. For more information about IDx and its innovative diagnostic solutions, visit www.eyediagnosis.net.